NCT04169711
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04169711
Title Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arrowhead Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site 1 Aurora Colorado 80045 United States Details
Research Site 2 Las Vegas Nevada 89169 United States Details
Research Site 4 Nashville Tennessee 37232 United States Details
Research Site 5 Dallas Texas 75390 United States Details
Research Site 6 Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field